Bleichroeder LP reported 53 positions worth $480.17M for the quarter ended Jun 30, 2026, down 5.3% on the prior quarter. It opened 4 new positions, added to 5, trimmed 7 and exited 8. Its largest holding is Spdr Gold Trust at 36.4% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| CUE Cue Biopharma, Inc. | +143.4K | +63.1% | $4.52M | 2.44% |
| COGT Cogent Biosciences, Inc. | +100.0K | – | $3.87M | 0.806% |
| DTIL Precision Biosciences Inc | +355.7K | +21.4% | $2.80M | 3.3% |
| CGEM Cullinan Therapeutics, Inc. | +150.0K | +150.0% | $2.73M | 0.948% |
| SPIR Spire Global, Inc. | +135.0K | – | $2.51M | 0.523% |
| RNTX Rein Therapeutics, Inc. | +1.00M | – | $1.04M | 0.217% |
| IPWR Ideal Power Inc. | +100.0K | +33.3% | $536.00K | 0.447% |
| BEAT HeartBeam, Inc. | +625.0K | – | $468.75K | 0.098% |
| GPGI GPGI, Inc. | +2,500 | +0.1% | $39.62K | 13.11% |
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| LIN Linde Plc | -8,040 | -11.7% | $4.17M | 6.53% |
| JPM Jpmorgan Chase & Co | -4,800 | -32.0% | $1.57M | 0.695% |
| POCI Precision Optics Corporation, Inc. | -270.9K | -100.0% | $1.19M | Exited |
| RTX RTX Corp | -6,000 | -100.0% | $1.16M | Exited |
| FLNT Fluent, Inc. | -285.7K | -20.0% | $1.07M | 0.888% |
| PXLW Pixelworks, Inc | -116.7K | -58.1% | $727.91K | 0.109% |
| SHAZ SharonAI Holdings Inc. | -25.0K | -100.0% | $568.25K | Exited |
| LHX L3Harris Technologies, Inc. | -1,600 | -100.0% | $552.24K | Exited |
| ICCC Immucell Corp | -51.6K | -50.8% | $518.52K | 0.105% |
| CARR CARRIER GLOBAL Corp | -6,000 | -100.0% | $337.86K | Exited |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| POCI Precision Optics Corporation, Inc. | -270.9K | $1.19M | 0.234% |
| RTX RTX Corp | -6,000 | $1.16M | 0.228% |
| SHAZ SharonAI Holdings Inc. | -25.0K | $568.25K | 0.112% |
| LHX L3Harris Technologies, Inc. | -1,600 | $552.24K | 0.109% |
| CARR CARRIER GLOBAL Corp | -6,000 | $337.86K | 0.067% |
| OTIS Otis Worldwide Corp | -3,000 | $231.24K | 0.046% |
| RVMD Revolution Medicines, Inc. | -556 | $54.07K | 0.011% |
| AVNW Aviat Networks, Inc. | -66 | $1.49K | <0.01% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | GLD Spdr Gold Trust | Others | 475.0K | $174.98M | 36.44% | 0 | 0.0% | Unchanged | 0.13% |
| 2 | GPGI GPGI, Inc. | Industrials | 3.97M | $62.96M | 13.11% | +2,500 | +0.1% | Added | 1.37% |
| 3 | RHLD Resolute Holdings Management, Inc. | Industrials | 314.2K | $45.41M | 9.46% | 0 | 0.0% | Unchanged | 3.88% |
| 4 | LIN Linde Plc | Basic Materials | 60.4K | $31.36M | 6.53% | -8,040 | -11.7% | Reduced | 0.01% |
| 5 | DUOT Duos Technologies Group, Inc. | Technology | 1.63M | $19.53M | 4.07% | 0 | 0.0% | Unchanged | 5.4% |
| 6 | DTIL Precision Biosciences Inc | Healthcare | 2.02M | $15.86M | 3.3% | +355.7K | +21.4% | Added | 7.63% |
| 7 | CUE Cue Biopharma, Inc. | Healthcare | 370.7K | $11.70M | 2.44% | +143.4K | +63.1% | Added | 5.85% |
| 8 | BX Blackstone Inc. | Financial Services | 90.8K | $10.68M | 2.22% | 0 | 0.0% | Unchanged | 0.01% |
| 9 | IMMX Immix Biopharma, Inc. | Healthcare | 1.00M | $10.31M | 2.15% | 0 | 0.0% | Unchanged | 1.4% |
| 10 | IDN Intellicheck, Inc. | Technology | 2.06M | $8.43M | 1.76% | -17.2K | -0.8% | Reduced | 10.15% |
| 11 | SPGI S&P Global Inc. | Financial Services | 20.0K | $8.15M | 1.7% | 0 | 0.0% | Unchanged | 0.01% |
| 12 | INVE INVE Technologies, Inc. | Technology | 2.88M | $7.27M | 1.51% | 0 | 0.0% | Unchanged | 11.91% |
| 13 | KZIA Kazia Therapeutics Ltd | Healthcare | 400.0K | $5.63M | 1.17% | 0 | 0.0% | Unchanged | 0% |
| 14 | COCH Envoy Medical, Inc. | Healthcare | 625.0K | $4.95M | 1.03% | 0 | 0.0% | Unchanged | 6.01% |
| 15 | CGEM Cullinan Therapeutics, Inc. | Healthcare | 250.0K | $4.55M | 0.948% | +150.0K | +150.0% | Added | 0.39% |
Tip. Select a row to see that position’s full history at Bleichroeder.
As of its Q2 2026 13F filing, Bleichroeder LP’s five largest positions were Spdr Gold Trust (GLD) at 36.4%, GPGI, Inc. (GPGI) at 13.1%, Resolute Holdings Management, Inc. (RHLD) at 9.5%, Linde Plc (LIN) at 6.5%, Duos Technologies Group, Inc. (DUOT) at 4.1% of the reported portfolio.
Bleichroeder LP reported a 13F portfolio worth $480.17M across 53 positions for Q2 2026. That is down 5.3% from the previous quarter.
Its largest purchases by value were Cue Biopharma, Inc. ($4.52M), Cogent Biosciences, Inc. ($3.87M), Precision Biosciences Inc ($2.80M). It opened 4 new positions.
Its largest sales by value were Linde Plc ($4.17M), Jpmorgan Chase & Co ($1.57M), Precision Optics Corporation, Inc. ($1.19M). It exited 8 positions entirely.
From the Form 13F-HR reports Bleichroeder LP files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.